Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Zoetis Shares Outstanding 2011-2024 | ZTS

Zoetis shares outstanding history from 2011 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
  • Zoetis shares outstanding for the quarter ending December 31, 2024 were 0.455B, a 1.61% decline year-over-year.
  • Zoetis 2024 shares outstanding were 0.455B, a 1.61% decline from 2023.
  • Zoetis 2023 shares outstanding were 0.462B, a 1.73% decline from 2022.
  • Zoetis 2022 shares outstanding were 0.47B, a 1.33% decline from 2021.
  
Zoetis Annual Shares Outstanding
(Millions of Shares)
2024 455
2023 462
2022 470
2021 477
2020 479
2019 482
2018 487
2017 493
2016 498
2015 502
2014 502
2013 500
2012 500
2011 500
2010 500
Zoetis Quarterly Shares Outstanding
(Millions of Shares)
2024-12-31 455
2024-09-30 454
2024-06-30 456
2024-03-31 459
2023-12-31 462
2023-09-30 461
2023-06-30 463
2023-03-31 465
2022-12-31 470
2022-09-30 469
2022-06-30 472
2022-03-31 474
2021-12-31 477
2021-09-30 476
2021-06-30 477
2021-03-31 478
2020-12-31 479
2020-09-30 479
2020-06-30 478
2020-03-31 479
2019-12-31 482
2019-09-30 482
2019-06-30 482
2019-03-31 483
2018-12-31 487
2018-09-30 486
2018-06-30 488
2018-03-31 490
2017-12-31 493
2017-09-30 492
2017-06-30 494
2017-03-31 495
2016-12-31 498
2016-09-30 498
2016-06-30 499
2016-03-31 500
2015-12-31 502
2015-09-30 502
2015-06-30 500
2015-03-31 503
2014-12-31 502
2014-09-30 502
2014-06-30 502
2014-03-31 501
2013-12-31 500
2013-09-30 500
2013-06-30 500
2013-03-31 500
2012-12-31 500
2012-09-30 500
2012-06-30 500
2012-03-31 500
2011-12-31
2010-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $70.491B $9.256B
Zoetis Inc. is a leader in the animal health space with a focus on both livestock and companion animals in seven major product categories: vaccines, anti-infectives, parasiticides, dermatology, other pharmaceutical products, medicated feed additives and animal health diagnostics. Zoetis has a diversified business, which caters to eight core species ' cattle, swine, poultry, fish and sheep (collectively, livestock) and dogs, cats and horses (collectively, companion animals). It directly markets its products to veterinarians and livestock producers. The outstanding growth rate in the companion animal medicines, vaccines and diagnostics sector is being driven by economic development, related increases in disposable income and a rise in pet ownership and spending on pet care.Zoetis has been working on strengthening its product portfolio through acquisitions and deals.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $80.367B 31.71
Takeda Pharmaceutical (TAK) Japan $44.101B 9.76
Daiichi Sankyo, - (DSNKY) Japan $43.319B 26.40
Sandoz Group AG (SDZNY) Switzerland $20.649B 0.00
Merck (MKKGY) Germany $18.495B 16.56
Astellas Pharma (ALPMY) Japan $17.499B 12.40
Summit Therapeutics (SMMT) United States $17.006B 0.00
United Therapeutics (UTHR) United States $16.401B 16.13
Shionogi (SGIOY) Japan $12.349B 12.37
Neurocrine Biosciences (NBIX) United States $11.577B 35.29
Orion OYJ (ORINY) Finland $7.681B 21.59
Madrigal Pharmaceuticals (MDGL) United States $7.656B 0.00
Corcept Therapeutics (CORT) United States $6.820B 51.66
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.245B 0.00
Stevanato Group S.p.A (STVN) Italy $6.199B 40.14
Ionis Pharmaceuticals (IONS) United States $5.197B 0.00
Grifols, S.A (GRFS) Spain $5.177B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.650B 9.52
Recursion Pharmaceuticals (RXRX) United States $4.044B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.418B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.630B 11.92
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.438B 14.57
Centessa Pharmaceuticals (CNTA) United Kingdom $2.208B 0.00
Hypermarcas (HYPMY) Brazil $2.185B 0.00
Soleno Therapeutics (SLNO) United States $2.045B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.945B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.755B 0.00
Evotec AG (EVO) Germany $1.581B 0.00
Dyne Therapeutics (DYN) United States $1.424B 0.00
Ardelyx (ARDX) United States $1.355B 0.00
Guardian Pharmacy Services (GRDN) United States $1.273B 0.00
Indivior (INDV) United States $1.240B 5.38
ARS Pharmaceuticals (SPRY) United States $1.145B 0.00
Ocular Therapeutix (OCUL) United States $1.140B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.121B 0.00
Xencor (XNCR) United States $1.105B 0.00
Harrow (HROW) United States $1.073B 0.00
Enliven Therapeutics (ELVN) United States $1.049B 0.00
Collegium Pharmaceutical (COLL) United States $0.959B 5.24
Avadel Pharmaceuticals (AVDL) Ireland $0.816B 0.00
Bioventus (BVS) United States $0.807B 25.51
Cronos Group (CRON) Canada $0.742B 0.00
Relay Therapeutics (RLAY) United States $0.685B 0.00
Verve Therapeutics (VERV) United States $0.663B 0.00
USANA Health Sciences (USNA) United States $0.612B 11.34
Xeris Biopharma Holdings (XERS) United States $0.592B 0.00
OmniAb (OABI) United States $0.548B 0.00
Elite Pharmaceuticals (ELTP) United States $0.531B 0.00
KalVista Pharmaceuticals (KALV) United States $0.526B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.475B 0.00
Altimmune (ALT) United States $0.472B 0.00
Savara (SVRA) United States $0.462B 0.00
ProKidney (PROK) United States $0.443B 0.00
Siga Technologies (SIGA) United States $0.437B 5.10
Organogenesis (ORGO) United States $0.425B 0.00
Zevra Therapeutics (ZVRA) United States $0.418B 0.00
Akebia Therapeutics (AKBA) United States $0.417B 0.00
Aldeyra Therapeutics (ALDX) United States $0.400B 0.00
Oruka Therapeutics (ORKA) United States $0.395B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.367B 148.79
Esperion Therapeutics (ESPR) United States $0.365B 0.00
Tourmaline Bio (TRML) United States $0.317B 0.00
CytoDyn (CYDY) United States $0.306B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.304B 0.00
Aquestive Therapeutics (AQST) United States $0.279B 0.00
Korro Bio (KRRO) United States $0.268B 0.00
Heron Therapeutics (HRTX) United States $0.262B 0.00
Avita Medical (RCEL) United States $0.261B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 15.31
Innate Pharma SA (IPHYF) France $0.243B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.241B 0.00
Inhibikase Therapeutics (IKT) United States $0.226B 0.00
Profound Medical (PROF) Canada $0.224B 0.00
4D Molecular Therapeutics (FDMT) United States $0.216B 0.00
Larimar Therapeutics (LRMR) United States $0.209B 0.00
MediWound (MDWD) Israel $0.201B 0.00
Lyell Immunopharma (LYEL) United States $0.193B 0.00
Nanobiotix S.A (NBTX) France $0.186B 0.00
Acrivon Therapeutics (ACRV) United States $0.182B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.179B 0.00
Nektar Therapeutics (NKTR) United States $0.177B 0.00
Aclaris Therapeutics (ACRS) United States $0.165B 0.00
VAXART, INC (VXRT) United States $0.160B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.150B 0.00
Silence Therapeutics (SLN) United Kingdom $0.150B 0.00
Champions Oncology (CSBR) United States $0.145B 0.00
Inotiv (NOTV) United States $0.143B 0.00
Lexeo Therapeutics (LXEO) United States $0.133B 0.00
Cassava Sciences (SAVA) United States $0.130B 0.00
ElectroCore (ECOR) United States $0.126B 0.00
Telomir Pharmaceuticals (TELO) United States $0.124B 0.00
Achieve Life Sciences (ACHV) Canada $0.111B 0.00
Cardiol Therapeutics (CRDL) Canada $0.107B 0.00
Journey Medical (DERM) United States $0.107B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.101B 0.00
Galectin Therapeutics (GALT) United States $0.092B 0.00
Metagenomi (MGX) United States $0.091B 0.00
Arch Biopartners (ACHFF) Canada $0.087B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.084B 0.00
Regulus Therapeutics (RGLS) United States $0.083B 0.00
Nutriband (NTRB) United States $0.082B 0.00
Protara Therapeutics (TARA) United States $0.081B 0.00
Pyxis Oncology (PYXS) United States $0.081B 0.00
FibroGen (FGEN) United States $0.078B 0.00
ESSA Pharma (EPIX) Canada $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.25
Karyopharm Therapeutics (KPTI) United States $0.077B 0.00
Avalo Therapeutics (AVTX) United States $0.074B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Mural Oncology (MURA) Ireland $0.072B 0.00
Fractyl Health (GUTS) United States $0.070B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.064B 0.00
Unicycive Therapeutics (UNCY) United States $0.063B 0.00
Dominari Holdings (DOMH) United States $0.063B 0.00
Gain Therapeutics (GANX) United States $0.062B 0.00
AleAnna (ANNA) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.055B 0.00
Iterum Therapeutics (ITRM) Ireland $0.052B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
Prelude Therapeutics (PRLD) United States $0.050B 0.00
AlloVir (ALVR) United States $0.050B 0.00
SCYNEXIS (SCYX) United States $0.042B 0.00
VYNE Therapeutics (VYNE) United States $0.040B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
NRx Pharmaceuticals (NRXP) United States $0.038B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
Surrozen (SRZN) United States $0.038B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.034B 0.00
PolyPid (PYPD) Israel $0.031B 0.00
BioVie (BIVI) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
Jupiter Neurosciences (JUNS) United States $0.028B 0.00
Natural Alternatives (NAII) United States $0.026B 0.00
DURECT (DRRX) United States $0.025B 0.00
Scienture Holdings (SCNX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
GlycoMimetics (GLYC) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.019B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
Lipocine (LPCN) United States $0.019B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.018B 0.00
MEI Pharma (MEIP) United States $0.018B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Traws Pharma (TRAW) United States $0.017B 0.00
Biomerica (BMRA) United States $0.016B 0.00
Citius Pharmaceuticals (CTXR) United States $0.016B 0.00
Cosmos Health (COSM) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
Lyra Therapeutics (LYRA) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 0.00
Nuvilex (PMCB) United States $0.013B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Mangoceuticals (MGRX) United States $0.012B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Indaptus Therapeutics (INDP) United States $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Relmada Therapeutics (RLMD) United States $0.009B 0.00
Ainos (AIMD) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.008B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.007B 0.00
Redhill Biopharma (RDHL) Israel $0.006B 0.00
CERo Therapeutics Holdings (CERO) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.08
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
Petros Pharmaceuticals (PTPI) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00